NCT01606488View on ClinicalTrials.gov

Effects of Brain Beta-Amyloid on Postoperative Cognition

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Postoperative Cognitive Dysfunction
Interventions
DRUG

Florbetapir F 18 (18F-AV-45)

Single IV bolus injection of 370 MBq (10mCi) florbetapir will be administered approximately 50 minutes prior to a 10 minute PET scan.

OTHER

no intervention

Trial Locations (1)

94121

San Francisco VA Medical Center, San Francisco

Sponsors

Collaborators (1)

Avid Radiopharmaceuticals
All Listed Sponsors
collaborator

Alzheimer's Drug Discovery Foundation

OTHER

collaborator

Avid Radiopharmaceuticals

INDUSTRY

lead

University of California, San Francisco

OTHER